Kyverna Therapeutics, Inc. KYTX Business Segments
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| External Research And Development Expenses Allocated By Program by Product | ||||||
| Other Program | $2.94M+56.5% | $3.29M-16.6% | $2.6M-46.9% | $2.35M-56.4% | $1.88M-68.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Kyverna Therapeutics, Inc. break its business down?
- Kyverna Therapeutics, Inc. (KYTX) reports external research and development expenses allocated by program by product across 2 parts — KYV One Zero One and Other Program. Each is extracted from the segment footnotes and tracked over time.
- Where does Kyverna Therapeutics, Inc.'s segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Kyverna Therapeutics, Inc.'s SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.